VetFolio’s Post

👨⚕️ Don't miss Prof. Ian Bruce talking about the Systemic Lupus Erythematosus Damage Index (SDI) revision! 📈 The SDI is a tool designed to track lupus progression and impacts treatment decisions worldwide. 🔍 The revised SDI aims to enhance accuracy, include pediatric cases, and update outdated definitions, ensuring that every patient’s condition is comprehensively evaluated. 🎥 Want to explore these updates in more detail and understand what they mean for patients and healthcare providers? Click the link to watch! https://lnkd.in/dmMDhxVP

I recently conducted my first study on Diabetic Foot and write a review article titled "Optimizing Diabetic foot ulcer healing: Impact of Controlled Diabetes, High Proteins intake, Offloading Strategies and Comprehensive Wound care" had the incredible opportunity to present my findings at the 2nd Global Conference on Advanced Wound Care and Wound Management. Here's to more research, learning, and contributing to advancements in wound care! #Research #DiabeticFoot #WoundCare #ProfessionalGrowth #ConferencePresentation

Esprit BTK Jennifer Jones-McMeans LinkedIn Over the past few weeks, I’ve had the pleasure to discuss the recent FDA approval of Abbott’s Esprit BTK Everolimus Eluting Resorbable Scaffold System and how this first-of-its-kind dissolvable stent has the potential to transform below-the-knee treatment. Historically, severe forms of peripheral artery disease (PAD) have been difficult to treat with limited therapy options and poor patient outcomes. The Esprit BTK System is changing this current standard of care by helping arteries stay open, so patients can live longer, healthier lives. Check out these articles to learn more: https://bit.ly/3wTHbb9 https://bit.ly/3XaFWiT https://bit.ly/4dUnrVx Important Safety Info: https://lnkd.in/ggnU9HFq #AbbottProud #CLTI #PeripheralArteryDisease

🔬 Exploring GERD: Understanding Gastroesophageal Reflux Disease 🔬 At MedTraits NY, we're dedicated to shedding light on common medical conditions to empower our community with knowledge and understanding. Today, let's delve into Gastroesophageal Reflux Disease (GERD). GERD occurs when stomach acid regularly flows back into the esophagus, causing discomfort and potentially leading to complications if left untreated. From heartburn and regurgitation to chest pain and difficulty swallowing, GERD symptoms can significantly impact one's quality of life. Our clinical research team at MedTraits NY is committed to advancing the understanding and treatment of GERD through innovative research initiatives. By collaborating with leading experts and employing state-of-the-art methodologies, we strive to enhance therapeutic options and improve patient outcomes. #MedTraitsNY #ClinicalResearch #GERD #HealthcareInnovation #empoweringcommunities

"Pain and Health-Related Quality of Life in Autosomal Dominant Polycystic Kidney Disease: Results from a National Patient-Powered Registry," has been classified as "high-impact" in this recent editorial in Kidney Medicine. https://lnkd.in/gspnzwvX Validated questionnaires, like that in our ADPKD Registry, play a crucial role in assessing ADPKD-related pain. We are grateful for the recognition and excited to continue improving the lives of those with ADPKD. Join us in making strides in ADPKD research ➡️ pkdcure.org/registry.

I say this a lot, but here’s another webinar you do NOT want to miss! Come learn about exercise and glycemic management from these outstanding experts 🏃🏼♀️🏋️♀️

We recently updated our white paper ‘Application of Breath VOCs in Asthma’ which provides an overview of the clinical applications of VOCs in asthma in relation to currently available alternatives. 🌬️ 🌐The whitepaper highlights VOCs that can reflect the type of immunological process that underlies inflammation in asthma, as well as predict exacerbations, and monitor treatment response. You can download our updated whitepaper for free here: https://ow.ly/gnS350T3YCc #asthma #biomarkers #exacerbation

Are you accurately identifying COPD patients with potential alpha-1 antitrypsin deficiency (AATD)? Dr. Charles Turck joins Dr. Brian Smith to unveil the subtle signs of AATD in seemingly healthy individuals, emphasizing the need for heightened vigilance in detection. Discover how a simple change in perspective can significantly impact patient outcomes. Tune into our discussion to transform your approach to COPD management: https://ow.ly/EVMi50QtGb6

When evaluating febuxostat and allopurinol, it's crucial to consider their comparative efficacy and safety profiles to guide treatment decisions for patients with gout and cardiovascular conditions. Read more 👉 https://lttr.ai/APf27 #IncreasedRisk #DrugAdministration #BoxedWarning #PrescribingInformation #TreatPatients #WarningHighlights #InhibitsXanthineOxidase #XanthineOxidaseInhibitor #GuideTreatmentDecisions #ChronicInflammatoryState

May is High Blood Pressure Education Month – the perfect time to share some important facts: ☑️Obesity is a risk factor for high blood pressure ⬆️ which is a major risk factor for heart disease. ☑️GLP-1 medications can have a positive impact on health outcomes – including a 20% reduction in major adverse cardiovascular events among patients taking semaglutide. Listen to our webinar to learn more about the research behind these game-changing medications for #WeightHealth. The webinar is hosted by a medical advisor for #WeightWatchers, Dr. Robert Kushner, who has played an integral role in the clinical research of GLP-1s. Listen here: https://bit.ly/3WGluG8 #GLP1s